Personalized medicine for non-small cell lung cancer: where are we now and where can we go?

Expert Rev Respir Med. 2018 Feb;12(2):81-82. doi: 10.1080/17476348.2018.1411805. Epub 2017 Dec 5.

Authors

Doreen A Ezeife¹, Natasha B Leighl¹

Affiliation

¹ a Division of Medical Oncology and Hematology , Princess Margaret Cancer Centre/University Health Network , Toronto , Canada.

PMID: 29187004
DOI: 10.1080/17476348.2018.1411805

No abstract available

Keywords: Personalized therapy; immunotherapy; molecular profiling; non-small cell lung cancer; targeted therapy.

Publication types

Editorial